Envestnet Asset Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
|
|||||
|
2025
Q1 | $1.17M | Sell |
|
|||||
|
2024
Q4 | $1.31M | Sell |
|
|||||
|
2024
Q3 | $1.46M | Sell |
|
|||||
|
2024
Q2 | $1.58M | Buy |
|
|||||
|
2024
Q1 | $1.52M | Buy |
|
|||||
|
2023
Q4 | $1.15M | Buy |
|
|||||
|
2023
Q3 | $874K | Buy |
|
|||||
|
2023
Q2 | $900K | Buy |
|
|||||
|
2023
Q1 | $687K | Buy |
|
|||||
|
2022
Q4 | $535K | Sell |
|
|||||
|
2022
Q3 | $623K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $239K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $281K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $155K | Hold |
|
|||||
|
2018
Q1 | $139K | Buy |
|
|||||
|
2017
Q4 | $127K | Buy |
|
|||||
|
2017
Q3 | $131K | Sell |
|
|||||
|
2017
Q2 | $165K | Buy |
|
|||||
|
2017
Q1 | $106K | Hold |
|
|||||
|
2016
Q4 | $98K | Buy |
|
|||||
|
2016
Q3 | $79K | Sell |
|
|||||
|
2016
Q2 | $179K | Buy |
|
|||||
|
2016
Q1 | $181K | Sell |
|
|||||
|
2015
Q4 | $926K | Sell |
|
|||||
|
2015
Q3 | $847K | Buy |
|
|||||
|
2015
Q2 | $904K | Sell |
|
|||||
|
2015
Q1 | $868K | Buy |
|
|||||
|
2014
Q4 | $769K | Sell |
|
|||||
|
2014
Q3 | $733K | Sell |
|
|||||
|
2014
Q2 | $816K | Sell |
|
|||||
|
2014
Q1 | $926K | Buy |
|
|||||
|
2013
Q4 | $799K | Buy |
|
|||||
|
2013
Q3 | $724K | Buy |
|
|||||
|
2013
Q2 | $225K | Buy |
|